Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$1.82 - $3.16 $2,520 - $4,376
-1,385 Reduced 4.03%
32,982 $79,000
Q3 2023

Nov 07, 2023

SELL
$3.17 - $7.91 $17,162 - $42,824
-5,414 Reduced 13.61%
34,367 $116,000
Q2 2023

Aug 04, 2023

SELL
$7.35 - $13.21 $78,975 - $141,941
-10,745 Reduced 21.27%
39,781 $292,000
Q1 2023

May 08, 2023

BUY
$7.79 - $16.29 $393,597 - $823,068
50,526 New
50,526 $523,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.